Pulmonary Venous Flow Patterns Associated with Long-term Mitral Transcatheter Edge-to-edge Outcomes.
Echocardiography
Outcomes
Pulmonary venous flow patterns
TEER
Journal
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
ISSN: 2241-5955
Titre abrégé: Hellenic J Cardiol
Pays: Netherlands
ID NLM: 101257381
Informations de publication
Date de publication:
29 May 2024
29 May 2024
Historique:
received:
26
02
2024
revised:
20
04
2024
accepted:
23
05
2024
medline:
1
6
2024
pubmed:
1
6
2024
entrez:
31
5
2024
Statut:
aheadofprint
Résumé
Transcatheter edge-to-edge repair (TEER) is a prominent therapeutic option for mitral regurgitation (MR) patients. However, it lacks objective parameters to assess procedural efficacy. This study aims to investigate the pulmonary venous (PV) flow as a surrogate for valvular hemodynamics and its associations to clinical outcomes. Consecutive MR patients who underwent TEER in our center from 01/2020-10/2021 were retrospectively investigated. PV flow parameters were measured before and after TEER, including velocity (cm/s), velocity time integral (VTI) (cm) and systolic/diastolic ratios. Primary outcomes were 1, 6, and 12 months heart failure hospitalizations (HFH) and 1 year all-cause mortality. The cohort consisted of 80 patients. The mean age was 74.76±10.13 years, 26 with primary and 54 with secondary MR. Systolic wave parameters improved significantly after TEER: mean peak-velocity increased from 9.94±31.95 to 35.74±15.03 cm/s, and VTI from 3.62±5.99 to 8.33±4.72 cm. Furthermore, systolic to diastolic VTI and peak-velocities ratios showed significant improvement 0.39±0.63 to 0.81±0.47 and 0.23±0.66 to 0.91±0.43 respectively. Using multivariable analysis, higher post-procedural S PV flow was significantly improved following TEER, and several hemodynamic parameters were associated HFH and mortality. These results may offer a basis for establishing future procedural goals to ensure better clinical outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
Transcatheter edge-to-edge repair (TEER) is a prominent therapeutic option for mitral regurgitation (MR) patients. However, it lacks objective parameters to assess procedural efficacy. This study aims to investigate the pulmonary venous (PV) flow as a surrogate for valvular hemodynamics and its associations to clinical outcomes.
METHODS
METHODS
Consecutive MR patients who underwent TEER in our center from 01/2020-10/2021 were retrospectively investigated. PV flow parameters were measured before and after TEER, including velocity (cm/s), velocity time integral (VTI) (cm) and systolic/diastolic ratios. Primary outcomes were 1, 6, and 12 months heart failure hospitalizations (HFH) and 1 year all-cause mortality.
RESULTS
RESULTS
The cohort consisted of 80 patients. The mean age was 74.76±10.13 years, 26 with primary and 54 with secondary MR. Systolic wave parameters improved significantly after TEER: mean peak-velocity increased from 9.94±31.95 to 35.74±15.03 cm/s, and VTI from 3.62±5.99 to 8.33±4.72 cm. Furthermore, systolic to diastolic VTI and peak-velocities ratios showed significant improvement 0.39±0.63 to 0.81±0.47 and 0.23±0.66 to 0.91±0.43 respectively. Using multivariable analysis, higher post-procedural S
CONCLUSIONS
CONCLUSIONS
PV flow was significantly improved following TEER, and several hemodynamic parameters were associated HFH and mortality. These results may offer a basis for establishing future procedural goals to ensure better clinical outcomes.
Identifiants
pubmed: 38821380
pii: S1109-9666(24)00119-2
doi: 10.1016/j.hjc.2024.05.015
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Hellenic Society of Cardiology. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Competing interests: None.